Reliable results
We use advanced technologies, tests, and methodologies to give you the most accurate results possible for your pediatric patients. This includes using digital droplet pulmonary chain reaction (ddPCR) to test for genetic hearing loss. Our technology is more reliable than all other genetic hearing loss tests used by other reference labs.
Demystifying the once unknown
One of the great challenges in interpreting genetic test results is understanding the role that variants of unknown significance may play in a child's diagnosis. But our technology and expertise changes this. Your care team will receive a detailed report that categorizes variants of unknown significance within the test result, so you can accurately pinpoint diagnosis.
Minimizing risk
To minimize the risk of human error in test result interpretation, we utilize technologies and develop unique tests that deliver unambiguous results. For instance, we use kappa free light technology to accurately test for multiple sclerosis (MS) in children. The standard MS test leaves room for human misinterpretation, while ours uses a mechanical process that gives a clear diagnostic result.
The latest
Nicole Boczek, Ph.D., co-director of Mayo Clinic's Genetics and Genomics Laboratory, explains the innovative new hereditary hearing loss panel now available through Mayo Clinic Laboratories. This comprehensive panel analyzes 160 genes associated with hereditary hearing loss, assessing for both nonsyndromic hearing loss, as well as syndromic hearing loss, which can be difficult to recognize clinically.
Nicole Boczek, Ph.D., co-director of Mayo Clinic's Genetics and Genomics Laboratory, explains the innovative new hereditary hearing loss panel now available through Mayo Clinic Laboratories. This comprehensive panel analyzes 160 genes associated with hereditary hearing loss, assessing for both nonsyndromic hearing loss, as well as syndromic hearing loss, which can be difficult to recognize clinically.
This “Specialty Testing” webinar will address the clinical presentations, evaluation (including diagnostic antibody testing), and treatment of autoimmune pediatric CNS disorders, including encephalitides and myelopathies.
Chromosome analysis, which was once the preferred genetic test for a wide variety of congenital abnormalities, is now one of the most frequently misordered cytogenetic tests at MML. This "Specialty Testing" webinar will outline the differences in technologies and the appropriate use of each test.